{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T04:30:17Z","timestamp":1698553817358},"reference-count":36,"publisher":"Wiley","issue":"S2","license":[{"start":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T00:00:00Z","timestamp":1312848000000},"content-version":"vor","delay-in-days":4817,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[1998,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>With the exception of childhood common acute lymphoblastic leukaemia (cALL), treatment of other hematopoietic B cell lineage tumours such as non\u2010 Hodgkin's lymphoma (B\u2010NHL), adult ALL and multiple myeloma (MM) is unsatisfactory. Similarly, the therapeutic outcome of acute and chronic myeloid leukaemia (AML, CML) is frequently dismal. At the same time, leukae\u2010 mia\/lymphoma cells represent ideal targets for immunotherapy. The present review summarizes our preclinical experience with a novel type of cytotoxic T cell based immunotherapy for B\u2010lineage and myeloid tumours. Staphylococcal enterotoxin\u2010derived superantigens (SAgs) are among the most potent T cell activators known, linking the T cell receptor to HLA\u2010DR on natural target cells. SAgs were genetically engineered to reduce DR binding and were then fused to Fab parts of tumour\u2010directed monoclonal antibodies (mAbs). Using these \u201ctargeted\u201d SAgs, highly efficient lysis of B\u2010lineage (B\u2010NHL, B\u2010CLL, ALL, MM) and myeloid (AML, CML) tumour cells by T\u2010cells was achieved in vitro and in an animal model. We are entering an interesting era of innovative cancer therapy based on novel man\u2010made biotherapeutic agents.<\/jats:p>","DOI":"10.1111\/j.1423-0410.1998.tb05461.x","type":"journal-article","created":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T14:31:57Z","timestamp":1312900317000},"page":"483-487","source":"Crossref","is-referenced-by-count":4,"title":["Targeted Superantigens for Immunotherapy of Haematopoietic Tumours"],"prefix":"10.1111","volume":"74","author":[{"given":"T.H.","family":"T\u00f6tterman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gidl\u00f6f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ragnarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"H\u00f6gbom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lindeberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"von der Lehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Einarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"S\u0153gaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kristensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kalland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dohlsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,8,9]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.10.2656"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.7.1497"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.6.2188"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.12.3457.bloodjournal85123457"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.V81.9.2263.2263","article-title":"Adjuvant immunotoxin therapy with anti\u2010B4\u2010blocked ricin after autologous bone marrow transplantation for patients with B\u2010cell non\u2010Hodgkin's lymphoma","volume":"81","author":"Grossbard ML","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7531365"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92225-3"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199308123290703"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199210223271705"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/362755a0"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0196-52"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.2.685.bloodjournal862685"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(96)00016-1"},{"key":"e_1_2_1_15_2","first-page":"95","article-title":"Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo","volume":"9","author":"Martinez\u2010Climent JA","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)00061-7"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1182\/blood.V77.11.2404.2404","article-title":"Anti\u2010MY9\u2010blocked\u2010ricin: An immunotoxin for selective targeting of acute myeloid leukemia cells","volume":"77","author":"Roy DC","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_18_2","first-page":"244","article-title":"Sequential targeted therapy for relapsed acute promyelocytic leukemia with all\u2010trans Retinoic acid and anti\u2010CD33 monoclonal antibody M195","volume":"9","author":"Jurcic JG","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.2.294"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.3.478"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1989.324"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood.V74.7.2335.2335","article-title":"Effects of recombinant interleukin\u20102 administration on cytotoxic effector function following intensive chemoradiotherapy","volume":"74","author":"Gottlieb DJ","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-6-853"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V76.6.1092.1092","article-title":"Hematologic and immunologic effects of recombinant interleukin\u20102 after autologous bone marrow transplantation","volume":"76","author":"Blaise D","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1995.tb07300.x"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2185544"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.22.9954"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.19.8945"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830180805"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.4049\/jimmunol.144.12.4663","article-title":"Production of TNF\u2010\u03b1 and TNF\u2010\u03b2 by staphylococcal enterotoxin A activated human T cells","volume":"144","author":"Fischer H","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_1_31_2","first-page":"96","article-title":"Targeting of human cytotoxic T lymphocytes to MHC class II\u2010expressing cells by staphylococcal enterotoxins","volume":"71","author":"Dohlsten M","year":"1990","journal-title":"Immunology"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/blood.V82.4.1230.1230","article-title":"Efficient killing of chronic B\u2010lymphocytic leukemia cells by superantigen\u2010directed T cells","volume":"82","author":"Wallgren A\u2010C","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_33_2","first-page":"1534","article-title":"Antibodies are capable of directing super\u2010antigen\u2010mediated T\u2010cell killing of chronic B lymphocytic leukemia cells","volume":"9","author":"Gidl\u00f6f C","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood.V89.6.2089","article-title":"A superantigen\u2010antibody fusion protein for T\u2010cell immunotherapy of human B\u2010lineage malignancies","volume":"89","author":"Gidl\u00f6f C","year":"1997","journal-title":"Blood"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1811.x"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1182\/blood.V89.10.3787","article-title":"Reed\u2010Sternberg cells of classical Hodgkin's disease react with the plasma cell\u2010specific monclonal antibody B\u2010B4 and express human syndecan\u20101","volume":"89","author":"Carbone A","year":"1997","journal-title":"Blood"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0609.1998.tb01029.x","article-title":"Antibody\u2010directed superantigen\u2010mediated T cell killing of myeloid leukaemic cell line cells","author":"Gidl\u00f6f C","year":"1998","journal-title":"Eur J Haematol"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1423-0410.1998.tb05461.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1423-0410.1998.tb05461.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T20:13:34Z","timestamp":1698524014000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1423-0410.1998.tb05461.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":36,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["10.1111\/j.1423-0410.1998.tb05461.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1423-0410.1998.tb05461.x","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}